STYX and breast carcinoma: A majority of study testified STYX acts as a latent oncogene, suggesting that STYX restrained cell apoptosis in colorectal and breast cancer by binding F-box and WD40 domain protein 7 (FBXW7, also called hCDC4, Fbw7) protein [11,15].